Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,008 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Ⅲ.N-1 Study].
Tangoku A, Toba H, Inoue H, Sasa S, Okumura K, Aoyama M, Inui T, Takizawa H. Tangoku A, et al. Among authors: okumura k. Gan To Kagaku Ryoho. 2020 Dec;47(12):1681-1686. Gan To Kagaku Ryoho. 2020. PMID: 33342983 Japanese. No abstract available.
Axillary lymphangioma that developed following COVID-19 vaccination: a case report.
Sasa S, Inoue H, Inui T, Miyamoto N, Aoyama M, Okumura K, Toba H, Yoshida T, Tezuka M, Hirose C, Saijo Y, Uehara H, Izumori A, Takahashi M, Sasa M, Takizawa H. Sasa S, et al. Among authors: okumura k. Surg Case Rep. 2022 Jul 8;8(1):131. doi: 10.1186/s40792-022-01488-5. Surg Case Rep. 2022. PMID: 35798903 Free PMC article.
Absolute Lymphocyte Count Changes During Neoadjuvant Chemotherapy are Associated With Prognosis of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Patients.
Miyamoto N, Inoue H, Inui T, Sasa S, Aoyama M, Okumura K, Toba H, Hino N, Nishisho A, Yukishige S, Kawanaka T, Takizawa H, Tangoku A. Miyamoto N, et al. Among authors: okumura k. Clin Breast Cancer. 2023 Apr;23(3):e68-e76. doi: 10.1016/j.clbc.2023.01.005. Epub 2023 Jan 12. Clin Breast Cancer. 2023. PMID: 36682907
Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer.
Sasa S, Inoue H, Nakagawa M, Toba H, Goto M, Okumura K, Misaki M, Inui T, Yukishige S, Nishisho A, Hino N, Kanematsu M, Bando Y, Uehara H, Tangoku A, Takizawa H. Sasa S, et al. Among authors: okumura k. Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00052-1. doi: 10.1016/j.clbc.2024.02.014. Online ahead of print. Clin Breast Cancer. 2024. PMID: 38462397
A Novel Risk Score for Major Bleeding in Japanese Patients with Non-Valvular Atrial Fibrillation: The J-RISK AF Study.
Akao M, Tomita H, Nakai M, Kodani E, Suzuki S, Hayashi K, Sawano M, Goya M, Yamashita T, Fukuda K, Tsuda T, Isobe M, Toyoda K, Miyamoto Y, Okamura T, Sasahara Y, Okumura K; J-RISK AF Research Group. Akao M, et al. Among authors: okumura k. J Atheroscler Thromb. 2024 May 28. doi: 10.5551/jat.64842. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 38811233
Virological characteristics of the SARS-CoV-2 KP.2 variant.
Kaku Y, Uriu K, Kosugi Y, Okumura K, Yamasoba D, Uwamino Y, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Among authors: okumura k. Lancet Infect Dis. 2024 May 20:S1473-3099(24)00298-6. doi: 10.1016/S1473-3099(24)00298-6. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38782005 No abstract available.
3,008 results